Lista de obras -

A case report: immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy.

artículo científico publicado en 1997

A functional link for major TCR expansions in healthy adults caused by persistent Epstein-Barr virus infection.

artículo científico publicado en 1998

A galectin-3 ligand corrects the impaired function of human CD4 and CD8 tumor-infiltrating lymphocytes and favors tumor rejection in mice

artículo científico publicado en 2010

A high-throughput panel for identifying clinically relevant mutation profiles in melanoma

artículo científico publicado en 2012

A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma

artículo científico publicado en 2011

An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3) ⬇️

artículo científico publicado el 1 de enero de 1990

Antigens for cancer immunotherapy.

artículo científico publicado en 2008

Breast cancer stem cells: implications for therapy of breast cancer.

artículo científico publicado en 2008

Characterization of the Melanoma miRNAome by Deep Sequencing

artículo científico publicado en 2010

Composite response of naive T cells to stimulation with the autologous lymphoblastoid cell line is mediated by CD4 cytotoxic T cell clones and includes an Epstein-Barr virus-specific component ⬇️

artículo científico publicado el 1 de febrero de 1991

Cross-platform array screening identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as genes frequently silenced by methylation in melanoma.

artículo científico publicado en 2011

Cross-presentation of a human malaria CTL epitope is conformation dependent.

artículo científico publicado en 2006

Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: implications for molecular mimicry in autoimmune disease

artículo científico publicado en 1999

Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4.

artículo científico publicado en 2015

Dendritic cell immunotherapy for stage IV melanoma

artículo científico publicado en 2007

Dominant cytotoxic T lymphocyte response to the immediate-early trans-activator protein, BZLF1, in persistent type A or B Epstein-Barr virus infection.

artículo científico publicado en 1997

Effect of pre-existing cytotoxic T lymphocytes on therapeutic vaccines

Exome Sequencing to Predict Neoantigens in Melanoma.

artículo científico publicado en 2015

Exploration of peptides bound to MHC class I molecules in melanoma

artículo científico publicado en 2015

Failure of Epstein-Barr virus-specific cytotoxic T lymphocytes to lyse B cells transformed with the B95-8 strain is mapped to an epitope that associates with the HLA-B8 antigen

artículo científico publicado el 1 de enero de 1992

Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing

artículo científico publicado en 2011

Fulminant infectious mononucleosis and recurrent Epstein-Barr virus reactivation in an adolescent.

artículo científico publicado en 2010

Generation of CD8(+) T cells expressing two additional T-cell receptors (TETARs) for personalised melanoma therapy.

artículo científico publicado en 2015

High efficiency ex vivo cloning of antigen-specific human effector T cells

artículo científico publicado en 2014

Identification of TFG (TRK-fused gene) as a putative metastatic melanoma tumor suppressor gene

artículo científico publicado en 2012

Immunological characteristics correlating with clinical response to immunotherapy in patients with advanced metastatic melanoma

artículo científico publicado en 2006

In vitro analysis of breast cancer cell line tumourspheres and primary human breast epithelia mammospheres demonstrates inter- and intrasphere heterogeneity.

artículo científico publicado en 2013

In vitro anti-tumour activity of alpha-galactosylceramide-stimulated human invariant Valpha24+NKT cells against melanoma.

artículo científico publicado en 2001

Interleukin-2 receptors in infectious mononucleosis

scientific article published on 01 December 1989

Lentiviral Vector-Mediated Tyrosinase-Related Protein 2 Gene Transfer to Dendritic Cells for the Therapy of Melanoma ⬇️

artículo científico publicado el 10 de diciembre de 2001

Lymphokine-activated killer (LAK) cells discriminate between Epstein-Barr virus (EBV)-positive Burkitt's lymphoma cells

artículo científico publicado en 1990

MHC class I-restricted exogenous presentation of a synthetic 102-mer malaria vaccine polypeptide

artículo científico publicado en 2005

Melanoma vaccines: developments over the past 10 years.

artículo científico publicado en 2011

Melanomas of unknown primary have a mutation profile consistent with cutaneous sun-exposed melanoma.

artículo científico

Microarray expression profiling in melanoma reveals a BRAF mutation signature.

artículo científico publicado en 2004

Nonresponsiveness to an immunodominant Epstein-Barr virus-encoded cytotoxic T-lymphocyte epitope in nuclear antigen 3A: implications for vaccine strategies

artículo científico publicado en 1991

Oligopeptide Induction of a Secondary Cytotoxic T-cell Response to Epstein-Barr Virus In Vitro ⬇️

artículo científico publicado el 1 de abril de 1991

Patterns of reactivity of Epstein-Barr virus-specific T cells in A-type donor cultures after reactivation with autologous A- or B-type transformants

artículo científico publicado en 1990

Proteomic comparison of mcf-7 tumoursphere and monolayer cultures

artículo científico publicado en 2012

Results of a phase I dendritic cell vaccine trial for malignant astrocytoma: potential interaction with adjuvant chemotherapy.

artículo científico publicado en 2008

Sequence variation of cytotoxic T cell epitopes in different isolates of Epstein-Barr virus

artículo científico publicado el 1 de enero de 1992

Small-molecule Bcl-2 inhibitors sensitise tumour cells to immune-mediated destruction.

artículo científico publicado en 2007

Spontaneous apoptosis of blood dendritic cells in patients with breast cancer.

artículo científico publicado en 2005

Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs, and p53.

artículo científico publicado en 2009

Treatment of non-resectable hepatocellular carcinoma with autologous tumor-pulsed dendritic cells

scientific article published on 01 August 2002

Tumor metastasis biopsy as a surrogate marker of response to melanoma immunotherapy

artículo científico publicado en 1999

Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours

artículo científico publicado en 2020

miR-514a regulates the tumour suppressor NF1 and modulates BRAFi sensitivity in melanoma.

artículo científico publicado en 2015

Lista de obras de

A case report: immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy.

A functional link for major TCR expansions in healthy adults caused by persistent Epstein-Barr virus infection.

A galectin-3 ligand corrects the impaired function of human CD4 and CD8 tumor-infiltrating lymphocytes and favors tumor rejection in mice

A high-throughput panel for identifying clinically relevant mutation profiles in melanoma

A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma

An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3) ⬇️

Antigens for cancer immunotherapy.

Breast cancer stem cells: implications for therapy of breast cancer.

Characterization of the Melanoma miRNAome by Deep Sequencing

Composite response of naive T cells to stimulation with the autologous lymphoblastoid cell line is mediated by CD4 cytotoxic T cell clones and includes an Epstein-Barr virus-specific component ⬇️

Cross-platform array screening identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as genes frequently silenced by methylation in melanoma.

Cross-presentation of a human malaria CTL epitope is conformation dependent.

Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: implications for molecular mimicry in autoimmune disease

Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4.

Dendritic cell immunotherapy for stage IV melanoma

Dominant cytotoxic T lymphocyte response to the immediate-early trans-activator protein, BZLF1, in persistent type A or B Epstein-Barr virus infection.

Effect of pre-existing cytotoxic T lymphocytes on therapeutic vaccines

Exome Sequencing to Predict Neoantigens in Melanoma.

Exploration of peptides bound to MHC class I molecules in melanoma

Failure of Epstein-Barr virus-specific cytotoxic T lymphocytes to lyse B cells transformed with the B95-8 strain is mapped to an epitope that associates with the HLA-B8 antigen

Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing

Fulminant infectious mononucleosis and recurrent Epstein-Barr virus reactivation in an adolescent.

Generation of CD8(+) T cells expressing two additional T-cell receptors (TETARs) for personalised melanoma therapy.

High efficiency ex vivo cloning of antigen-specific human effector T cells

Identification of TFG (TRK-fused gene) as a putative metastatic melanoma tumor suppressor gene

Immunological characteristics correlating with clinical response to immunotherapy in patients with advanced metastatic melanoma

In vitro analysis of breast cancer cell line tumourspheres and primary human breast epithelia mammospheres demonstrates inter- and intrasphere heterogeneity.

In vitro anti-tumour activity of alpha-galactosylceramide-stimulated human invariant Valpha24+NKT cells against melanoma.

Interleukin-2 receptors in infectious mononucleosis

Lentiviral Vector-Mediated Tyrosinase-Related Protein 2 Gene Transfer to Dendritic Cells for the Therapy of Melanoma ⬇️

Lymphokine-activated killer (LAK) cells discriminate between Epstein-Barr virus (EBV)-positive Burkitt's lymphoma cells

MHC class I-restricted exogenous presentation of a synthetic 102-mer malaria vaccine polypeptide

Melanoma vaccines: developments over the past 10 years.

Melanomas of unknown primary have a mutation profile consistent with cutaneous sun-exposed melanoma.

Microarray expression profiling in melanoma reveals a BRAF mutation signature.

Nonresponsiveness to an immunodominant Epstein-Barr virus-encoded cytotoxic T-lymphocyte epitope in nuclear antigen 3A: implications for vaccine strategies

Oligopeptide Induction of a Secondary Cytotoxic T-cell Response to Epstein-Barr Virus In Vitro ⬇️

Patterns of reactivity of Epstein-Barr virus-specific T cells in A-type donor cultures after reactivation with autologous A- or B-type transformants

Proteomic comparison of mcf-7 tumoursphere and monolayer cultures

Results of a phase I dendritic cell vaccine trial for malignant astrocytoma: potential interaction with adjuvant chemotherapy.

Sequence variation of cytotoxic T cell epitopes in different isolates of Epstein-Barr virus

Small-molecule Bcl-2 inhibitors sensitise tumour cells to immune-mediated destruction.

Spontaneous apoptosis of blood dendritic cells in patients with breast cancer.

Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs, and p53.

Treatment of non-resectable hepatocellular carcinoma with autologous tumor-pulsed dendritic cells

Tumor metastasis biopsy as a surrogate marker of response to melanoma immunotherapy

Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours

miR-514a regulates the tumour suppressor NF1 and modulates BRAFi sensitivity in melanoma.